FTC Protects Consumers by Requiring Valeant to Sell Three Prescription Drugs as Condition to Acquire Rival Dermatology Businesses from Sanofi and Johnson and Johnson
Protecting competition in the market for three topical dermatology drugs, the Federal Trade Commission has approved orders requiring Valeant Pharmaceuticals International, Inc. to divest three drugs used to treat different skin ailments, as conditions of acquiring Ortho Dermatologics, Inc. from Johnson and Johnson, and Dermik Laboratories, Inc. from Sanofi.
View full post on Federal Trade Commission (FTC) – Text of Press Releases
Acquire, businesses, Condition, Consumers, Dermatology, Drugs, From, Johnson, Prescription, Protects, Requiring, rival, Sanofi, sell, Three, Valeant
RSS Site Feed